Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Bought by Sanctuary Advisors LLC

Sanctuary Advisors LLC grew its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBHFree Report) by 5.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 18,175 shares of the company’s stock after purchasing an additional 927 shares during the period. Sanctuary Advisors LLC’s holdings in Prestige Consumer Healthcare were worth $1,425,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Huntington National Bank boosted its position in shares of Prestige Consumer Healthcare by 39.9% during the 3rd quarter. Huntington National Bank now owns 635 shares of the company’s stock valued at $46,000 after purchasing an additional 181 shares in the last quarter. International Assets Investment Management LLC raised its position in shares of Prestige Consumer Healthcare by 7,112.5% in the third quarter. International Assets Investment Management LLC now owns 1,154 shares of the company’s stock valued at $83,000 after purchasing an additional 1,138 shares during the period. Covestor Ltd grew its stake in shares of Prestige Consumer Healthcare by 95.6% in the third quarter. Covestor Ltd now owns 1,338 shares of the company’s stock worth $96,000 after acquiring an additional 654 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of Prestige Consumer Healthcare by 18.9% in the fourth quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock worth $108,000 after acquiring an additional 220 shares during the last quarter. Finally, Blue Trust Inc. boosted its stake in Prestige Consumer Healthcare by 102.4% during the third quarter. Blue Trust Inc. now owns 1,755 shares of the company’s stock worth $121,000 after buying an additional 888 shares in the last quarter. 99.95% of the stock is owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Trading Up 2.8 %

Shares of PBH stock opened at $87.46 on Wednesday. The company has a market cap of $4.33 billion, a PE ratio of 20.48, a price-to-earnings-growth ratio of 2.69 and a beta of 0.50. The stock’s 50 day simple moving average is $79.53 and its two-hundred day simple moving average is $76.75. Prestige Consumer Healthcare Inc. has a 1 year low of $62.35 and a 1 year high of $88.36. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20.

Prestige Consumer Healthcare (NYSE:PBHGet Free Report) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. Research analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Analyst Ratings Changes

PBH has been the subject of several analyst reports. StockNews.com upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. Canaccord Genuity Group raised their price target on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a report on Friday, February 7th. Sidoti downgraded Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 target price for the company. in a report on Monday, December 9th. Raymond James upgraded Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. Finally, Oppenheimer lifted their price objective on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a research note on Thursday, February 13th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $92.60.

View Our Latest Research Report on Prestige Consumer Healthcare

Prestige Consumer Healthcare Company Profile

(Free Report)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

See Also

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.